Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 327-332

  Grosser, Tilo ^a   Zucker, Tom Philipp ^a   Weber, Artur Aron ^a   Schulte, Kerstin ^b   Sachinidis, Agapios ^b   Vetter, Hans ^b   Schrör, Karsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Coronary artery smooth muscle cell; Mitogenesis; PDGF (platelet derived growth factor); Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; THROMBOXANE A2; 7 (3 (3 HYDROXY 4 (4' IODOPHENOXY) 1 BUTENYL) 7 OXABICYCLO(2.2.1)HEPTAN 2 YL) 5 HEPTENOIC ACID; 7-(3-(3-HYDROXY-4-(4'-IODOPHENOXY)-1-BUTENYL)-7-OXABICYCLO(2.2.1)HEPTAN-2-YL)-5-HEPTENOIC ACID; CALCIUM; DNA; DRUG DERIVATIVE; FUSED HETEROCYCLIC RINGS; MITOGENIC AGENT; PROSTAGLANDIN ENDOPEROXIDE; PROTEIN C FOS; UNSATURATED FATTY ACID; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ARTICLE; CATTLE; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; MITOGENESIS; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; METABOLISM; VASCULAR SMOOTH MUSCLE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CALCIUM; CATTLE; CELL DIVISION; CELLS, CULTURED; CORONARY VESSELS; DNA; FATTY ACIDS, UNSATURATED; MITOGENS; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0030614709     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00860-6     Document Type: Article

References (24)

1. 2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta, Atherosclerosis 72, 245.
2. 2 stimulates vascular smooth muscle hypertrophy by upregulating the synthesis and release of endogenous basic fibroblast growth factor, J. Biol. Chem. 268, 17397.
3. Bauters, C., J.M. Lablanche, E.P. McFadden, M. Hamon and M.E. Bertrand, 1995, Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis, Circulation 92, 2473.
4. Bradford, M., 1976, A rapid and sensitive method for the quantitation of microgramm quantities of protein using the principle of protein-dye binding, Anal. Biochem. 72, 248.
5. Chirgwin, J.J., R.J. Przybyla, R.J. MacDonald and W.J. Rutter, 1979, Isolation of biologically active ribonucleic acid from sourced enriched in ribonuclease, Biochemistry 18, 5294.
6. Crowley, S.T., E.C. Demsey, K.B. Horwitz and L.D. Horwitz, 1994, Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate, Circulation 90, 1908.
7. De Groote, P., C. Bauters, E.P. McFadden, J.M. Lablanche, F. Leroy and M.E. Bertrand, 1995, Local lesion-related factors and restenosis after coronary angioplasty: evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty, Circulation 91, 986.
8. 2 stimulated signal transduction in vascular smooth muscle, J. Pharmacol. Exp. Ther. 265, 447.
9. Dorn II, G.W., M.W. Becker and M.G. Davis, 1992, Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle, J. Biol. Chem. 267, 24897.
10. Fallier-Becker, P., J. Rupp, J. Fingerle and E. Betz, 1990, Smooth muscle cells from rabbit aorta, in: Cell Culture Techniques in Heart and Vessel Research, ed. H.M. Piper (Springer, Berlin) p. 247.
11. Grosser, T., D. Bönisch, T.-Ph. Zucker and K. Schrör, 1995, Iloprost-induced inhibition of proliferation of coronary artery smooth muscle cells is abolished by homologous desensitization, Agents Actions Suppl. 45, 85.
12. 2 in vascular smooth muscle cells, Biochem. Pharmacol. 40, 2535.
13. Harker, L.A., 1987, Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty, Am. J. Cardiol. 60, 20B.
14. Inui, H., Y. Kitami, M. Tani, T. Kondo and T. Inagami, 1994, Differences in signal transduction between platelet-derived growth factor (PDGF) α and β receptors in vascular smooth muscle cells, J. Biol. Chem. 269, 30546.
15. Jones, D.A., C.W. Benjamin and D.A. Linseman, 1995, Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades, Mol. Pharmacol. 48, 890.
16. 2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase, J. Biol. Chem. 269, 5693.
17. 2 on proliferation of vascular smooth muscle cells from rats, Am. J. Physiol. 263, H1331.
18. Ross, R., 1993, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362, 801.
19. Sachinidis, A., K. Schulte, Y. Ko, K. Meyer zu Brickwedde, V. Hoppe, J. Hoppe and H. Vetter, 1993, The induction of early response gene in rat smooth muscle cells by PDGF-AA is not sufficient to stimulate DNA-synthesis, FEBS Lett. 319, 221.
20. 2 and vascular smooth muscle cell proliferation, Hypertension 26, 771.
21. Schrör, K. and H. Schröder, 1994, Eicosanoids and smooth muscle function, in: Handb. Exp. Pharmacol. 111: Pharmacology of Smooth Muscle, ed. L. Szekeres and J. Gy Papp (Springer, Heidelberg) p. 127.
22. Schwartz, R.S., D.R. Holmes and E.J. Topol, 1992, The restenosis paradigm revisited: an alternative proposal for cellular mechanisms, J. Am. Coll. Cardiol. 20, 1284.
23. Uehara, Y., T. Ishimitsu, K. Kimura, M. Ishii, T. Ikeda and T. Sugimoto, 1988, Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats, Prostaglandins 36, 847.
24. Zucker, T.-P., D. Bönisch and K. Schrör, 1995, Thromboxane potentiates thrombin- and thrombin receptor activating peptide (TRAP)-induced mitogenesis of coronary artery smooth muscle cells, Circulation 92 (Suppl.), I-111 (Abstract).